SBTX — Skinbiotherapeutics Share News
0.000.00%
- £15.55m
- £13.36m
- £4.64m
Brief: SkinBioTherapeutics Appoints Rachel Parsonage As Interim CEO
SkinBioTherapeutics - Appointment of Interim CEO
Brief: SkinBioTherapeutics Says Co Appointed Alyson Levett To Oversee Continuing Investigation Process
Ftse Indexes Mixed At Start Of Data: heavy week, Pinewood plunges (updated)
SkinBioTherapeutics slumps most since 2020 on profit warning amid probe against former CEO
SkinBioTherapeutics warns on profit amid misconduct probe against former CEO (updated)
UK Stocks-Factors to watch on February 16 (updated)
UK's SkinBioTherapeutics probes former CEO, issues fiscal 2026 profit warning
Brief: SkinBioTherapeutics Says Martin Hunt Assumes Role Of Executive Chairman Temporarily
Brief: SkinBioTherapeutics Says CEO Stuart Ashman Resigns After Suspension
SkinBioTherapeutics - Resignation of CEO
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics - Issue of Equity and Total Voting Rights
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics - Issue of Equity and Total Voting Rights
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics - Holding(s) in Company
Brief: SkinBioTherapeutics Promotes Emily Bertram To Chief Financial Officer